Serum amyloid A delivers retinol to intestinal myeloid cells to promote adaptive immunity
Author(s) -
YeJi Bang,
Zehan Hu,
Yun Li,
Sureka Gattu,
Kelly A. Ruhn,
Prithvi Raj,
Joachim Herz,
Lora V. Hooper
Publication year - 2021
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.abf9232
Subject(s) - retinol , myeloid , vitamin , retinoic acid , lrp1 , immunology , ldl receptor , immunity , biology , acquired immune system , chemistry , microbiology and biotechnology , immune system , biochemistry , lipoprotein , cholesterol , gene
SAAving vitamin A–mediated immunity The vitamin A metabolite retinol is critical for B and T cell development and homing to the gut. Intestinal myeloid cells such as dendritic cells and macrophages take up retinol and process it into retinoic acid (RA), which in turn initiates RA-dependent gene expression programs in lymphocytes. Banget al . identified LDL receptor-related protein 1 (LRP1) as a myeloid cell surface receptor for retinol. LRP1 binds retinol chaperoned by serum amyloid A (SAA) proteins, and SAA–retinol complexes are then endocytosed and metabolized by myeloid cells. Mice lacking either Saa or myeloid-specific Lrp1 exhibited profound impairments in vitamin A–mediated immunity. B and T cell trafficking to the intestine, immunoglobulin A production by B cells, and protection from entericSalmonella Typhimurium infection were all diminished when either of these crucial players was missing. —STS
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom